Search PubMed⌕ Search

Biomedical subjects

J Walker

Publications and source records attributed to J Walker.

At least 433 records · Page 24Linked to original sources
PubMed1982

Azo reduction of sulphasalazine in healthy volunteers.

1 A comparison of total sulphapyridine saliva concentrations resulting from administration of sulphapyridine and sulphasalazine at equimolar doses has been carried out. It is concluded that the extent of azo reduction of sulphasalazine to release sulphapyridine is complete in healthy volunteers. 2 An ampicillin course of treatment alters the azo reduction of sulphasalazine. The extent of cleavage is reduced by one third on average. There is no change in the rate of absorption of the release sulphapyridine. 3 An ampicillin course of treatment does not alter the disposition of sulphapyridine. The changes noted in acetyl conjugate plasma concentrations are entirely consistent with reduced availability of sulphapyridine.

Ampicillin↗
PubMed1982

The photography as a catalyst in psychotherapy.

This paper focuses upon the use of photographers as a projective method enabling the patient and therapist to more readily explore transferential feelings, penetrate resistance, work through conflicts, and mobilize affect. The photographs are ambiguous and abstract but have a semblance of reality. They are unstructured, which by design permits interpretation. The patient can project upon the photograph his way of seeing life, his meanings, significances, patterns, relationships, and especially feelings. I am using the photographic images of the primary purpose of therapeutics in contrast to an emphasis on diagnostic usage. What is important is the dialogue and thematic content that follows from the response. The catalytic use of photographs is an alternate strategy to explore the unconscious. It helps the patient verbalize, recognize feelings, fantasize and often to realize an untrapped storehouse of imagination and/or creative potential. Finally, this method allows the patient to become more aware of his/her unique perception of the world. "The Photograph As A catalyst in Psychotherapy" should not be viewed as a strategy in and of itself, but rather should be utilized as an integral part of the psychotherapeutic process.

Adult↗
PubMed1982

Pituitary apoplexy complicating chronic secondary amenorrhea.

Three young women who developed amenorrhea secondary to large, unsuspected pituitary tumors are described. They presented with acute onset of the triad of headache, nausea and vomiting, and visual abnormalities. One patient died; the other two retained some sequelae, and one had a significant hemiparesis. These devastating effects of pituitary apoplexy can be avoided in amenorrheic patients if the possibility of a pituitary tumor is considered early on. Lateral skull x-ray examinations are inexpensive an easily obtained and will usually demonstrate significant pituitary tumors. Early recognition and surgical removal of pituitary tumors carries low morbidity and mortality and will avoid an apoplectic crisis.

Adult↗
PubMed1981

NAD+, ADP-ribosylation and transcription in permeabilized mammalian cells.

When permeabilized hamster fibroblasts were incubated with 4 mM-NAD+, the substrate for poly(ADP-ribose) polymerase, RNA polymerase I activity was inhibited by about 85%. This inhibition was not relieved by prior incubation of cells with 3-aminobenzamide, a potent inhibitor of the poly(ADP-ribose) polymerase. Digestion of cells with pancreatic deoxyribonuclease I resulted in the inhibition of RNA polymerase I by 80% and the activation of poly(ADP-ribose) polymerase by up to 300%; prior incubation with 3-aminobenzamide did not prevent the inhibition of the RNA polymerase activity. No radioactivity was found associated with RNA polymerase I during later stages of purification of this enzyme from permeabilized cells previously incubated with [14C]NAD+. The inhibitory effect of NAD+ on RNA polymerase I was not specific for NAD+, as other small, negatively charged molecules with a nuclear location also inhibited the enzyme. The results do not support the concept of a role for ADP-ribosylation in transcription catalysed by RNA polymerase I.

Animals↗
PubMed1981

Antibody responses of monkeys to oral and local immunization with Streptococcus mutans.

Monkeys were immunized with Streptococcus mutans by a number of routes in an attempt to elicit exclusively a secretory immunoglobulin A (IgA) response. Antibody responses were detected by a sensitive radioimmunoassay. Monkeys primed subcutaneously and boosted submucosally with formolized cells of S. mutans had high serum IgG, IgA, and IgM radioimmunoassay titers and only slight salivary IgG titers. Instillation of killed cells of S. mutans into the right parotid salivary duct elicited good IgG, IgA, and IgM responses in both the right parotid saliva and serum, but only a weak IgM response was detected in the left parotid saliva. Administration of killed cells of S. mutans in enterically coated capsules did not elicit a detectable antibody response or have a discernible effect on the antibody response to subsequent immunization by instillation. No increase in antibody titer was detected in the serum or whole saliva from monkeys orally immunized with enterically coated capsules containing viable S. mutans or in the serum, whole saliva, or intestinal contents from monkeys immunized with uncoated capsules containing killed cells of the same organism. These results do not support the concept that oral immunization with S. mutans is effective in stimulating a generalized secretory IgA response in primates.

Administration, Oral↗
PubMed1981

Kinetics of cytolytic T lymphocyte binding to target cells in suspension.

Cytolytic T lymphocytes (CTL) were able to specifically bind and lyse allogeneic P815 tumor cells and LPS blast cells in suspension. An assay was developed to measure the rate of target cell binding in suspension independent of the rate of lysis. Target cell binding was found to plateau within 3 hr in suspension. The presence of free, functional CTL and targets at these plateaus was demonstrated, indicating that target cell binding was an equilibrium process. Scatchard plots were used to derive values for Kd (apparent affinity) and bmax (maximum binding). Target cell binding in suspension could not be blocked by purified plasma membranes. Target cell binding was compared for CTL generated by secondary in vitro stimulation with intact cells or with purified membranes. These 2 CTL populations yielded distinct values for Kd and bmax. Implications of this kinetic difference for CTL recognition of purified plasma membranes are discussed.

Animals↗
PubMed1980

Clinical pharmacokinetics of alcuronium chloride in man.

The pharmacokinetic behaviour of alcuronium is described for nineteen patients undergoing anaesthesia for elective surgery. Eleven patients received a single bolus intravenous dose of 0.25 mg/kg, while 8 patients required additional doses of 0.125 mg/kg. A two-compartment open model was found to describe adequately both the single dose and multiple dose data for the majority of patients. No significant differences were found in the model-independent pharmacokinetic parameters between the single and multiple dose studies. Mean values for the pooled data for the half-life (t 1/2 beta), apparent volume of distribution (Vd beta), volume of distribution at steady-state (Vdss), volume of the central compartment (Vc) and plasma clearance (Clp) were 198.75 min, 24.261, 20.891, 8.181 and 90.22 ml/min respectively. Evoked muscle twitch response was monitored in 17 of the patients to assess the degree of relaxant blockade. The bolus dose of alcuronium produced complete block in 9 patients and between 95 and 99% block in the remainder. The time of onset to maximum block ranged from 3 to 30 min with the concurrently measured plasma levels of alcuronium being 0.79 to 2.25 microgram/ml. The time taken following bolus administration to 5% recovery (95% paralysis) was a mean of 42 min and the corresponding mean alcuronium plasma concentration was 0.78 microgram/ml.

Adult↗
PubMed1980

Sleep state and seizure foci related to depth spike activity in patients with temporal lobe epilepsy.

Depth spike activity was evaluated from medial temporal lobe sites using computer spike recognition techniques in all-night sleep records derived from 10 patients with medically refractory complex partial seizures. Sleep stages were classified into 1 of 4 groups: wakefulness, REM sleep, light sleep and deep sleep. Some disturbance in the periodicity of the sleep cycle was noted in most patients, but the relative proportions of REM sleep, light sleep and deep sleep were close to that reported for normals. Depth spike activity was observed to be most frequent in a majority of sites during deep sleep in 6 patients and during light sleep in 3 patients. In 1 patient equal numbers of sites showed maximal activation during light sleep and deep sleep. In 4 patients, certain sites in the more epileptogenic lobe demonstrated a maximal rate during waking or REM sleep. All patients reported in this study were considered to be suitable for temporal lobectomy. In contrast to the results obtained from a previous study, the side with the site demonstrating maximal mean spike rate did not necessarily correspond to the side chosen for lobectomy. Significant correspondence across patients between the more epileptogenic lobe and maximal spike rate was not found during waking and was further reduced during light sleep and deep sleep. The correspondence was, however, significant during REM sleep and for the side containing the site demonstrating the smallest activation in mean spike rate during light sleep or deep sleep relative to waking. These results indicate that an analysis of sleep induced changes in depth spike activity can be useful in improving predictions concerning epileptogenicity. Quantification of other aspects of the interictal EEG, such as background activity, may further improve such predictions.

Adolescent↗
PubMed1980

Organic contaminants in direct coal liquefaction--a preliminary assessment.

Area samples taken at two coal liquefaction facilities were analyzed by either gas chromatography or gas chromatography/mass spectrometry to identify the types of organic contaminants to which workers may be exposed. Results indicate that the contaminants consisted primarily of one or two ring low-molecular weight aromatic compounds.

Coal↗
PubMed1980

Effect of lecithin on disability and plasma free-choline levels in Friedreich's ataxia.

Four patients with Friedreich's ataxia took part in an open trial, in which they consumed 50-100g/day lecithin granules (containing approximately 22% phosphatidycholine) for 16 weeks, but no improvement resulted. Several unwanted effects including diarrhoea, nausea, depression, "hot flushes" and weakness were experienced. Resting levels of free-choline in plasma were within the range found in 19 normal subjects. Sixteen other patients with Friedreich's ataxia also had normal free-choline levels. Treatment with lecithin significantly increased plasma free-choline levels, but there was a trend for these to fall towards baseline levels, despite continued ingestion of lecithin.

Adolescent↗